Is there a generic for Ifosfamide?

Yes. The FDA Orange Book lists 5 approved generic (ANDA) applications for Ifosfamide, referencing the brand IFEX. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Ifosfamide?

IFEX (NDA 019763, BAXTER HLTHCARE) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Ifosfamide are approved?

Ifosfamide is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Ifosfamide

Ifosfamide is approved as 1 brand and 5 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:IFEX · NDA 019763

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
IFEXRLD×2	BAXTER HLTHCARE	NDA 019763	AP	Dec 30, 1988

Generic (ANDA) products (5)

Product	Applicant	Application	TE	Approved
IFOSFAMIDE×2	EXTROVIS	ANDA 201689	—	Nov 26, 2012
IFOSFAMIDE×2	HIKMA	ANDA 076619	AP	Jun 29, 2011
IFOSFAMIDE×2	FRESENIUS KABI USA	ANDA 090181	—	Sep 22, 2009
IFOSFAMIDE×2	MEITHEAL	ANDA 076657	AP	Apr 04, 2007
IFOSFAMIDE×2	FRESENIUS KABI USA	ANDA 076078	AP	May 28, 2002

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ifosfamide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo